180 likes | 391 Views
Hypothetical Clinical Trial Phase II Trial Combined Anti-Vascular/Chemotherapy. . Pre-Rx. Surgery. Baseline. . . 2m. 4m. Mid-Rx. . . Post-Rx. . Early Rx. . Anti-vascular agent Taxane. Doxorubicin Cyclophoshamide. Endpoint: pCR rate. Discussion. Exploratory imaging endpointsWhat imaging?What ti
E N D